Navigation Links
Fourth Annual James E. Marshall OCD Foundation Beyond Beauty Dinner to Honor E. Scott Beattie, Chairman and CEO, Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO, Conde Nast Publications



Cure... CNN's Soledad O'Brien to Emcee and 'Torch Singer' Andrea Marcovicci to


NEW YORK, Feb. 11 /PRNewswire/ -- On Tuesday, February 12, 2008, The James E. Marshall OCD Foundation, which benefits genetic research and awareness for Obsessive-Compulsive Disorder, will honor E. Scott Beattie, Chairman and Chief Executive Officer of Elizabeth Arden, Inc. and Charles H. Townsend, President and CEO of Conde Nast Publications, at the fourth annual Beyond Beauty dinner. The event to be held at the Union League in New York City, will feature Soledad O'Brien, anchor and special correspondent for CNN, as master of ceremonies, and will include a special performance by singer Andrea Marcovicci.

Founded in 2003 by the family of its namesake, The James E. Marshall OCD Foundation funds genetic research and aims to increase awareness of Obsessive Compulsive Disorder, a disease that affects one in four children and countless adults worldwide. Frequently misunderstood and financially under-funded, the costs of OCD exceed those of heart disease, cancer and diabetes combined. Funds raised by the Beyond Beauty dinner will go to Johns Hopkins School of Medicine and will be allocated by Dr. Gerald Nestadt, head of the Department of Psychiatry and Behavioral Science.

"Unless touched by this horrible disease firsthand, most people do not understand how truly devastating OCD can be -- not just for the sufferers, but for family, friends, and co-workers, who see how destructive the behavior can be," says Linda Marshall, President of Elysee Scientific Cosmetics. "Our biggest ally in changing public perceptions is the media, which can help shed light on this disease and stimulate discussion so we can erase the stigma associated with mental disorders. This is our mission: Awareness, Discovery, Cure."

E. Scott Beattie is Chairman and Chief Executive Officer of Elizabeth Arden Inc., a global prestige beauty products company. Since the inception of the business in 1992, Mr. Beattie has been involved in every element of Elizabeth Arden's expansion and development. During the fiscal year ending June 2007, net sales were over $1.1 billion. Elizabeth Arden products are sold in over 90 countries worldwide. Mr. Beattie has dedicated himself to building an organization that is entrepreneurial in spirit, utilizes a team- based approach, focusing on the needs of both its consumers and its retail partners and counts and treats its employees as its most valued resource.

Charles H. Townsend is President and Chief Executive Officer of Conde Nast Publications, home to many of the world's most celebrated magazines and websites, including Vogue, Allure, Vanity Fair, Glamour, GQ,, Wired,, Conde Nast Portfolio, and The New Yorker. Since becoming CEO of the company in January 2004, Mr. Townsend has overseen the consolidation of Advance Magazine Group's diverse publishing assets under the Conde Nast Publications banner. Today, Conde Nast publishes twenty-six consumer magazines and their websites, eight commercial websites, and three business- to-business trade publications.

While the beauty industry is committed to helping people look beautiful on the outside, this event highlights how the industry helps them feel beautiful within as well, thus the name "Beyond Beauty."

For more information on The James E. Marshall Foundation please visit:

SOURCE The James E. Marshall OCD Foundation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. LCA-Vision Reports Fourth Quarter and Full-Year 2007 Financial Results
2. NightHawk Radiology Holdings, Inc. Announces Time Change for Fourth Quarter and Full-Year 2007 Earnings Conference Call
3. Huntsman to Discuss Fourth Quarter and Full Year 2007 Results on Friday, February 22, 2008
4. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
5. NHP Announces Fourth Quarter Earnings Release Date and Conference Call/Webcast
6. CardioDynamics Reports Fourth Quarter and Fiscal 2007 Results with 10% Revenue Growth in 2007
7. HCA Reports Fourth Quarter - Year End 2007 Results
8. DRAXIS Health Reports Fourth Quarter and Year End Results
9. inc. Achieves GAAP Profitability in the Fourth Quarter of 2007
10. PPD Reports Fourth Quarter and Year-End 2007 Financial Results
11. Emageon Inc. to Host Fourth Quarter 2007 Financial Results Conference Call February 21, 2008
Post Your Comments:
(Date:11/27/2015)... Francisco, California (PRWEB) , ... November 27, 2015 , ... ... Janis Joplin Ann Arbor Michigan boxing style concert posters. This is one of Joplin's ... at the Canterbury House at the University of Michigan in Ann Arbor. The According ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... substance abuse located in central Michigan, have come together on Thanksgiving Day to ... produced video, available for viewing on the Serenity Point YouTube channel, patients displayed ...
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... ... a real-time eReferral system for diagnostic imaging in the Waterloo region. Using the ... and Nuclear Medicine tests directly from their electronic medical record (EMR) without the ...
(Date:11/26/2015)... ... , ... The Catalent Applied Drug Delivery Institute today announced ... form selection in early phase drug development. The first of these is to ... the UK’s emerging life sciences companies, corporate partners, and investors, at Milton Park, ...
(Date:11/26/2015)... ... November 26, 2015 , ... PRMA Plastic Surgery is updating their record ... performed their 6,000th free flap breast reconstruction surgery! , “What an accomplishment for the ... to rebuild lives and it’s an honor to have served all of these women.” ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... , Países Bajos, November 26, 2015 ... la terapia fotodinámica de Bremachlorin para el cáncer avanzado. ... la inmunoterapia con la terapia fotodinámica de Bremachlorin para ... Un nuevo enfoque combina la inmunoterapia con la terapia ... Clinical Cancer Research . --> ...
(Date:11/26/2015)... , November 26, 2015 --> ... to use SyMRI to find optimal contrast weighting of MRI ... metastases, and has signed a research agreement with SyntheticMR in ... hospital. Using SyMRI, it is possible to generate multiple contrast ... after the patient has left, thus making it possible to ...
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
Breaking Medicine Technology: